AVTX icon

Avalo Therapeutics
AVTX

Overview Fund Trends Analyst Outlook Journalist POV

24 hedge funds and large institutions have $159K invested in Avalo Therapeutics in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

82% less capital invested

Capital invested by funds: $863K → $159K (-$704K)

Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$34K
2
+$19.8K
3
+$18.1K
4
BCV
Banque Cantonale Vaudoise
Switzerland
+$10K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$6.35K

Top Sellers

1
-$444K
2
-$198K
3
-$15.7K
4
Millennium Management
Millennium Management
New York
-$12.1K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$4.62K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1
27
–
28
–
29
–
30
–
31
–
32
–
33
–
1
2